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Background:  Reported  cases  of  potassium  overdoses  have  shown  that  this  condition  could
generate several  morbidities,  mainly  related  to cardiac  dysrhythmias  even  with  fatal  out-
comes  in  some  cases.
Potassium salts  in  extended  release  tablets  could  form  pharmacobezoars  if a large  amount
is ingested.  In relation  to the  above,  when  the  patient  has  a pharmacobezoar,  clinical  ﬁnd-
ings may  be delayed  and  may  persist.
The techniques  available  for  removal  of a pharmacobezoar  are  whole  bowel  irrigation
(WBI),  endoscopy  or in some  surgery  [1].  Endoscopy  as  a decontamination  method  has
shown  promising  results.
Case report:  A  42  year old  woman,  who  intentionally  ingested  100  tablets  of  extended  release
potassium  chloride,  50  mg  of clonazepam  and an  undisclosed  amount  of  ethanol,  presented
with metabolic  acidosis,  hyperlactatemia  and  sinus  tachycardia  2  h  after  ingestion.  Gastric
lavage  and  activated  charcoal  were  applied  initially,  speciﬁc  measures  were  not  neces-
sary.  However,  a  transcutaneous  pacemaker  was  placed.  Because  of  her  background,  we
considered a  pharmacobezoar  and  an  endoscopy  were  performed  to remove  99  tablets  of
potassium that  were  isolated  or forming  concretions.
Discussion: The  readily  available  techniques  to remove  a pharmacobezoar  are  whole  bowel
irrigation (WBI)  and  endoscopy;  nevertheless  there  is  not  a consensus  about  their  relative
merits. Our patient  was  treated  by  endoscopy  because  we  found  on the  X-ray  a conglom-
erate  of radiopaque  images  suggesting  a  pharmacobezoar.  In this  case  we  did  not  have  any
adverse effect.
Conclusions:  We  consider  
a drug  bezoar  from  the  sto
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Fig. 1. Abdominal radiography with multiple radioopacities in the stom-
ach (red arrow).210 P.T.J. Guillermo et al. / Tox
1. Background
Extended release potassium salts are indicated in
induced or acquired hypokalemic conditions. The potas-
sium  overdose could generate hyperkalemic states, espe-
cially  if the patient has impaired renal function or if there
has  been a large ingestion of salts (toxic dosage: 2 mEq/kg)
[1].  When a patient presents a large ingestion of extended
release potassium tablets, clinical manifestations could be
delayed  even more than 24 h and concretions could be
formed  in the stomach. Concretions complicates the decon-
tamination by gastric lavage, so that after this procedure in
these  patients, it is possible to ﬁnd tablets remaining in the
stomach,  even in 88.2% of cases [2].
The great absorption that follows to a massive ingestion
of  potassium salts causes myocardial conduction distur-
bances and metabolic acidosis.
The correct technique for gastrointestinal decontami-
nation in cases of massive overdose of extended-release
tablets is not well established, nowadays, toxicologists con-
tinue  to consider use of whole bowel irrigation (WBI),
endoscopy or even surgery to evacuate tablet remaining
from the stomach [1].
2.  Case report
A  42 year old woman with history of borderline person-
ality disorder and a suicide attempt with potassium salts
(50  tablets) one year earlier presented to the emergency
room after intake of 100 tablets of extended release potas-
sium  chloride (1000 mEq), 50 mg  of liquid clonazepam, and
an  undisclosed amount of ethanol at home.
She recognized this as a new suicide attempt and pre-
sented with somnolence, tachycardia and exhalation of
ethanol  odor 2 h after ingestion. Her vital signs were: blood
pressure 130/90 mm Hg, pulse was 97 beats/min, respira-
tions  were 22 breaths/min, temperature was 36.5 ◦C, and
oxygen  saturation was 98% on room air.
A 12 lead electrocardiogram demonstrated sinus tachy-
cardia with normal QRS duration and unaltered T-waves.
Potassium level was 3.9 mmol/L, blood gas analysis
revealed pH 7.25, HCO3 17.5 mEq/L and lactate 4.9 mmol/L.
A  standard toxicological screen was negative for all agents.
Ethanol level was 90.80 mg/dl. Finally a plain ﬁlm of the
abdomen showed multiple opacities in the region of the
stomach (Fig. 1). Other agents, including acetaminophen
and salicylates were reported to be absent.
A venous access was  placed. After that, a gastric lavage
with a 20-french orogastric tube (maximum size in our hos-
pital)  was performed. However, no tablets were recovered
during this procedure. Also, a single dose of activated char-
coal  was performed in order to treat a possible coingestant.
Anti-hyperkalemic measures were not necessary at that
time.  However, a transcutaneous pacemaker was placed.
Given  her background and the gastric lavage that was
ineffective, an abdominal radiography was performed in
order  to identify the location of the tablets. The radiography
showed multiple radiopacities in the stomach and the pos-
sibility  of a pharmacobezoar was considered. Consultation
with the gastroenterology service was done to request an
endoscopy for removal of the suspected pharmacobezoar.Fig. 2. Endoscopic removal of the tablets.
A total of 99 of the 100 tablets that were either isolated
or forming concretions were removed with an endoscopic
basket (Figs. 2 and 3).
After  gastric decontamination, clinical outcome was sat-
isfactory, pharmacological correction of acidosis was not
needed  and she did not develop hyperkalemia or cardio-
vascular impairments. The patient was intubated for the
procedure and extubated 18 h later. After that, she was
discharged to the psychiatry service 48 h later.3.  Discussion
The potassium excess could be absorbed by the intra-
cellular compartment to maintain serum levels under
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the  equipment was introduced eighteen times and no com-
plications  were presented. For this reason, we  consider the
endoscopic  removal of bezoars a therapeutical option for
Table 1
Case  development.
Time Serumpotassium,
blood gas
Therapeutics
Arrival K 3.9 mmol/L Parenteral solutions
pH  7.25, HCO3
17, Lact
4.9 mmol/L
Not  Anti hyperkalemic
measures.
Transcutaneouspacemaker
Endoscopy
5 h
(after  endoscopy)
K 3.5 mmol/L Not Anti
hyperkalemicmeasures
pH  7.39, HCO3
18.3, Lact
0.6  mmol/L
8 h K 3.4 mmol/L Not AntiFig. 3. R
.5 mEq/L, but unfortunately this mechanism is saturable
3].  In this context, potassium serum levels over 6.0 mEq/L
hould  be considered risky and need to be treated immedi-
tely  [4,5]. Although there is no clear relationship between
he  serum level and heart rhythm disturbances, we know
hat  the risk of dysrhythmias is increased if rapid absorp-
ion  of potassium occurs [1,4,6,7].
Many drugs are capable to form concretions as in
he  case of amitriptyline, salicylates, carbamazepine, iron,
otassium salts and other extended release preparations,
ith or without an enteric coat [8–11].
The gastric decontamination is an essential procedure
n the treatment of patients with an oral drug overdose;
owever, the appropriate technique to remove a bezoar is
till  controversial.
The gastric lavage and activated charcoal administra-
ion have both been demonstrated to be poorly effective on
atients  with pharmacobezoars. Moreover, in Mexico there
re  no orogastric tubes with a recommended diameter to
emove  extended release tablets (36–40 Fr).
Nowadays, the available techniques to remove phar-
acobezoars include: WBI  (only small size bezoars),
ndoscopy and surgical extraction. In this context, the
ain  factors to consider before selecting a decontamina-
ion technique are: drug toxicity, pharmacobezoar size and
ocation,  clinical condition of the patient and availability of
he  resources (polyethylene glycol, operating room, etc.)
10].
Despite  the fact that WBI  has been demonstrated in
ome  reports be safe and to improve the clinical condition
f  these patients, at this time there is no strong evidence of
ts  efﬁcacy. It requires several hours to clarify the efﬂuent,
lso, it is necessary to have a normal bowel function and
t  could not be effective if a big bezoar exists in the stom-
ch.  In the case of perforation, intestinal occlusion, active
leeding, hemodynamic instability or vomiting, the WBI
re  contraindicated [12]. Also, in the case of a potassium
alts overdose, one of the most important causes of morbid-
ty  is the cardiac rhythm disturbance with hemodynamic
nstability, which limits the use of WBI. tablets.
We considered the high risk of massive absorption with
hemodynamic implications and started management with
airway  protection, placement of a pacemaker and decon-
tamination by endoscopy [13]. Furthermore, our patient
had  a history of a previous suicide attempt with 50 tablets
of  extended release potassium salts. She developed hyper-
kalemia, metabolic acidosis and hyperacute T waves, and
was  hospitalized seven days in an intensive care unit. In
the  second attempt, even though the patient increased
the ingestion to 100 tablets of the same drug, she did not
develop  any complication and was discharged two days
after  ingestion. We strongly concur that if a pharmacobe-
zoar is suspected endoscopy should be considered in order
to  avoid a massive absorption [10,14,21].
On the other hand, the multiple introductions of the
endoscope could increase the risk of airway injuries and
aspiration of gastric content [15]. Despite that, in our case,hyperkalemicmeasures
18 h K 4.3 mmol/L Not Anti hyperkalemic
measures. Transcutaneous
pacemaker was  removed
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uncomplicated patients and should be performed early if
the  medical center is short of appropriate orogastric tubes
[1,16].
Gunja  [17] describes a case of a patient who  ingested
100 tablets of extended release potassium chloride with
severe  hyperkalemia 5 h after the ingestion [17]. Also,
Saxena [18] describes a case of a woman who ingested
16 mEq/Kg of potassium salts and developed severe hyper-
kalemia  with cardiac arrest in the ﬁrst hour after the
ingestion. Finally, Colledge [19] reported another case with
an  intake of approximately 100 tablets with hyperkalemia
and ventricular tachycardia demonstrating the effects of a
rapid  absorption in massive ingestions of potassium salts.
In  our case, due to the early endoscopic removal of tablets,
the  patient did not increase potassium serum levels and
complications were not registered.
Table 2
Reported cases.
Report Patient Time
(intake)
Extended  release KCl 
Charles et al. (1978) 32, F 18 h 47 tabs (8 mmol) 
Illingworth  (1980) [22] 36, M 5 h Unknown
Tabs, 8 mmol
Colledge  et al. (1988) 24, F 2 h 100 tabs 
Steedman (1988) [25] 27, F 12 h 60 tabs (8 mmol) 
Peeters  et al. (1998) 62, F ? 300 tabs (2.4 mmol) 
58,  M 5 h 20 tabs of extended
release  KCl (630 mg).
Bendoﬂurazide and
phenylbutazone
26,  M 3.5 h 10 tabsdextro-
propoxyphene –
acetaminophen
40  tabs of extended
release  KCl (8 mmol)
2
months
M
24  h 5 tabs (8 mmol) 
Whitaker et al. (2000) [26] 30
months
M
30  min  32 tabs 
Su  (2001) [27] 50, F 1 h 100 tabs (10 mEq)
Alprazolam and
ibuprofen
17 a, M 10 h 20–30 tabs (10 mEq) 
Wan  (2007) [24] 86, M Chronic 70 tabs (8 mmol) 
Gunja  (2011) 42, F 90 min  40 tabs (8 mmol) 
42,  F 5 h 100 tab (8 mmol) 
6,  M 2 h 10–20 tab (8 mmol) 
Saxena  (1988) 46, F 1 h 100 tab (8 mmol) 
Briggs  Albert et al. (2013) [28] 44, F 75 min  30 tab (20 mEq) 
Pérez  et al. (2013) 42, F 2 h 100 tab (10 mEq) 
1: gastric lavage; 2: whole bowel irrigation; 3: endoscopy; 4: hemodialysis; 5: ca
exchange  resin; 10: furosemide; 11: activated charcoal; 12: mannitol; 13: cardiaeports 1 (2014) 209–213
4. Conclusions
This was  a case of intentional potassium, ethanol and
clonazepam overdose resulting in mild metabolic acidosis,
hyperlactatemia and sinus tachycardia at 2 h after inges-
tion,  without hyperkalemia and after utilizing endoscopy
in  order to remove 100 isolated tablets and forming phar-
macobezoars. In this case, the bezoar formation could lead
to  massive absorption of potassium and increase the risk of
hyperkalemic disturbances. In addition to standard treat-
ments  for hyperkalemia, this case report demonstrates
the beneﬁt from endoscopy in extended-release potassium
bezoar formation, considering the hospital resources, time
from  the ingestion and clinical status of the patient. Also,
this  study asks whether endoscopy should be used as an
initial  measure of decontamination in patients who have
Findings Serum K Therapy
Diarrhea, death 10.8 mmol/l
(intraocular)
0
Wide complex tachycardia
(125×)
8.9 mml/l 5, 6, 7, 9, 10
Hyperacute T waves, sinus
tachycardia  110×.
Ventricular tachycardia
6.4 mmol/l 1, 5, 6, 7
1st degree AV blockade,
QRS  widening and
hyperacute  T waves
9.1 mmol/l 5, 6, 7, 9,12
Abdominal distension. One
month later gastric
necrosis
Not report 3
Left ventricular heart
failure
8 mmol/l 1, 6, 9, 10
Unaltered EKG. Nausea and
vomiting, Asystole, death
in  gastric lavage
9.3 mmol/l 1
Death 10.1 mmol/l 0
Tachycardia (155×) 1st
degree  AV blockade.
Hyperacute T waves
9.2 mmol/l 2, 5, 6, 9, 10
Hyperacute T waves 8.2 mmol/l 1, 2, 4, 5, 6, 7, 9, 13
Tachycardia, nausea,
vomiting  and diarrhea
5.5 mmol/l 2
Asthenia and adinamia 6.8 mmol/l 2, 5, 6, 7
Tachycardia (100×) 5.5 mmol/l 6, 2
Tachycardia (124×) 8.5 mmol/l 5, 6, 7, 4
Plane T waves 7.6 mmol/l 4, 5, 6, 7, 8.
Cardiac arrest 9.6 mmol/l 1, 5, 6, 7, 9, 11, 14.
Mildly peaked T waves 7.3 mmol/L 2, 3, 5, 6, 7, 8.
Metabolic acidosis,
hyperlactatemia and sinus
tachycardia  with normal T
waves
3.9 mmol/L 1, 3, 11
lcium; 6: insulin/glucose; 7: sodium bicarbonate; 8: -2 agonist; 9: ion
c pacemaker and 14: advanced cardiac resuscitation.
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ngested a large quantity of tablets, particularly in centers
here there is a lack of adequate tubes for gastric lavage
Table 1).
We  concur that in selected cases endoscopy could be
sed  instead of gastric lavage as ﬁrst decontamination mea-
ure,  although, a clinical guideline for the use of endoscopy
s  a decontamination method still need to be created.
Cases of extended release potassium salts reported are
ummarized below (Table 2).
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